Details for Australian Trade Mark No. 1111647 (hide)

Owner Anormed Inc.

Convention CA 8 November 2005 1,278,906

Service Phillips Ormonde Fitzpatrick

Filing Date 2 May 2006

Classes

Class 5 Pharmaceutical and medicinal preparations including such preparations for the treatment of HIV, inflammation, arthritis, asthma, cancer, cell transplants, cell transplant rejection, organ transplants, organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular diseases, lymphoma, tissue regeneration, tissue repair, leukaemia, drug-induced anaemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells, ophthalmic diseases, age related macular degeneration and diabetic retinopathy

Event Publications

18 May 2006 Application filed

18 May 2006 Application Accepted

14 September 2006 Trade Mark Registered/Protected

17 January 2008 Subsequent Owners/Holder Registered - Full Assignment

  Anormed Inc. is the full asignee of Genzyme Corporation.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1111648-PULP JUICE BARS

1111646-SOFTVU